Insulin analogues: new therapies for type 2 diabetes mellitus.

被引：4

作者：

Bethel M.A. ^{[1
]}

Feinglos M.N. ^{[1
]}

机构：

[1] Department of Medicine, Duke University Medical Center, Box 3921, Durham, 27710, NC

来源：

Current Diabetes Reports | 2002年 / 2卷 / 5期

关键词：

Insulin Glargine; Insulin Analogue; Insulin Aspart; Insulin Lispro; Insulin Detemir;

D O I：

10.1007/s11892-002-0104-4

中图分类号：

学科分类号：

摘要：

Insulin therapy is ultimately necessary for the control of blood glucose in a majority of patients with type 2 diabetes mellitus. Unfortunately, the pharmacokinetic characteristics of previously available rapid-, intermediate-, and long-acting preparations make sustained normoglycemia almost impossible. Advances in molecular genetic engineering have made possible the development of insulin analogues with pharmacokinetics that more closely mimic the needs of patients with type 2 diabetes. In the following article, we explore the insulin analogues currently available for clinical use, their pharmacokinetics, and the rationale for their use in the treatment of type 2 diabetes, and follow-up with a brief examination of future developments.

引用

页码：403 / 408

页数：5

共 83 条

[1]

Perley MJ(1967)Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects J Clin Invest 46 1954-1962

[2]

Kipnis DM(1984)Pre-type 1 diabetes: linear loss of beta-cell response to intravenous glucose Diabetes 33 717-720

[3]

Srikanta S(1984)Diminshed B-cell secretory capacity in patients with noninsulin dependent diabetes mellitus J Clin Invest 76 1318-1328

[4]

Ganda OP(1967)The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects J Clin Invest 46 1549-1557

[5]

Gleason RE(2001)Recombinant DNA technology in the treatment of diabetes: insulin analogs Endocr Rev 22 706-717

[6]

Ward WK(1999)Insulin analogues and their potential in the management of diabetes mellitus Diabetologia 42 1151-1167

[7]

Bolgiano DC(1999)Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients Diabetes 48 99-105

[8]

McKnight B(1997)Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes Diabetes Care 20 1539-1542

[9]

Bagdade JD(2000)Therapy focused on lowering post-prandial glucose, not fasting glucose, may be superior for lowering HbA1c Diabetes Care 23 1236-1241

[10]

Bierman EL(1997)Mealtime treatment with insulin analog improves post-prandial hyperglycemia and hypoglycemia in patients with noninsulin-dependent diabetes mellitus Arch Intern Med 157 1249-1255

← 1 2 3 4 5 6 7 8 9 →